News & Progress
Press Releases
- June 21, 2018
Palleon Pharmaceuticals Appoints Lori Hu of Vertex Ventures HC to Board of Directors - December 12, 2017
Palleon Pharmaceuticals Signs Exclusive License Agreement with King’s College London for Intellectual Property Related to Glycoimmune Checkpoints to Treat Cancer - October 04, 2017
Palleon Pharmaceuticals Raises $47.6 million to Develop Glycoimmune Checkpoint Inhibitors, a New Class of Medicines Designed to Overcome Resistance to First-Generation Immuno-Oncology Drugs
@Palleon_Pharma • Sep 18, 2018
We're hiring! Do you have an interest in developing biomarker assays for a fast-paced #ImmunoOncology startup? We'r… http://WkKosiWSCB
@Palleon_Pharma • Sep 17, 2018
Check out this excellent summary of Palleon scientific board member Heinz Laubli's recent article in… http://nBgtcuCHag